Home 2023

FDA policy

Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale
Artificial Intelligence

Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale

Jonathan D Grinstein, PhD -
0
Nonviral Platforms Streamline Gene Therapy Delivery
Drug Discovery

Nonviral Platforms Streamline Gene Therapy Delivery

Kathy Vuksanaj -
0
Novel Molecule Targets Inflammation in Alzheimer’s Models
Drug Discovery

Novel Molecule Targets Inflammation in Alzheimer’s Models

Christina Jackson -
0
Draft Cell and Gene Therapy Guidance Document Calls for Comparability and Lifecycle Management
Bioprocessing

Draft Cell and Gene Therapy Guidance Document Calls for Comparability and Lifecycle Management

Christina Jackson -
0
Omicron Vaccine Boosters Receive FDA Emergency Use Authorization
Coronavirus

Omicron Vaccine Boosters Receive FDA Emergency Use Authorization

Julianna LeMieux, PhD -
0
FDA Expands EUA for Pfizer/BioNTech COVID-19 Vaccine
Coronavirus

FDA Expands EUA for Pfizer/BioNTech COVID-19 Vaccine

Alex Philippidis -
0
Pfizer’s COVID-19 Pill Receives FDA Authorization
Coronavirus

Pfizer’s COVID-19 Pill Receives FDA Authorization

Julianna LeMieux, PhD -
0
After Patient Death, FDA Places Hold on Pfizer DMD Gene Therapy Trial
Drug Discovery

After Patient Death, FDA Places Hold on Pfizer DMD Gene Therapy Trial

Alex Philippidis -
1
And Then There Were Four: VBI Scores First FDA Approval with Hepatitis B Vaccine
Coronavirus

And Then There Were Four: VBI Scores First FDA Approval with Hepatitis B Vaccine

Alex Philippidis -
0
Pfizer-BioNTech COVID-19 Vaccine Gets FDA’s EUA for Use in Children Aged 5–11
Coronavirus

Pfizer-BioNTech COVID-19 Vaccine Gets FDA’s EUA for Use in Children Aged 5–11

Julianna LeMieux, PhD -
0
123...5Page 1 of 5
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.